T 0632

02/01/1997 - "These results suggest that CCK plays an important role in progression and aggravation of acute pancreatitis, and T-0632 may have a therapeutic value in these disease states."
02/01/1997 - "We conclude that T-0632 showed preventive effects on all of these pancreatitis models by oral or intraduodenal administration. "
02/01/1997 - "Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis."
09/26/1996 - "The effect of T-0632 for caerulein-induced pancreatitis was 4-fold more potent than that for gallbladder emptying. "
09/26/1996 - "In mice, orally administered T-0632 prevented caerulein-induced pancreatitis, CCK-8-induced inhibition of gastric emptying and CCK-8-induced gallbladder emptying in dose-dependent manners with ED50 values of 0.028, 0.04, and 0.12 mg/kg, respectively. "